We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Pergamum Reports Positive Data from Phase II Clinical Trial of PXL-01

News   Jun 27, 2013

 
Pergamum Reports Positive Data from Phase II Clinical Trial of PXL-01
 
 
 

RELATED ARTICLES

Gene Therapy Restores Immunity in Infants With Rare Immunodeficiency Disease

News

A small clinical trial has shown that gene therapy can safely correct the immune systems of infants newly diagnosed with a rare, life-threatening inherited disorder in which infection-fighting immune cells do not develop or function normally.

READ MORE

Evolution of Antibody Response to Dengue Virus Teased Out

News

The human immune response to infection with dengue (a close "cousin" of the Zika virus) has been teased out and may provide guidance to those formulating vaccines.

READ MORE

Pain, Pain Go Away: Game to Improve Kids' Vaccine Experiences

News

The CARD System (Comfort, Ask, Relax, Distract) is an evidence-based approach that can be implemented as an in-class game to help students better prepare for vaccination clinics, thereby improving their experiences.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE